Epitomics enter program agreement for antibody technology Epitomics.

Real wood, Ph.D., Senior VP and Mind of Global Biologics, Bayer HealthCare.. Bayer, Epitomics enter program agreement for antibody technology Epitomics, Inc. Today that it has signed something contract with Bayer Schering Pharma AG announced, Germany . Epitomics use its proprietary rabbit monoclonal antibody technology to create antibodies for Bayer HealthCare’s drug focus on identification and validation. Epitomics has already established a long-standing encounter with Bayer Health care.In 2014 June, FAU's College of Medication welcomed its inaugural class of 36 residents in its initial University-sponsored residency in internal medication. Boca Raton Regional Medical center is the major site for this program, with participation from Bethesda Medical center East and Delray INFIRMARY. These are three of the five hospitals in the GME Consortium.. Clinical trial shows dalfampridine tablets improve going for walks ability in MS patients Acorda Therapeutics, Inc.